Back
Actuate Therapeutics, Inc. Stock Predictions
$0.85 Entry Open - Fortune 1000 AI Tech in Demand
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
51
ACTU
Actuate Therapeutics, Inc.
Last Price:
$7.34
Seasonality Move:
-23.17%
7 Day Trial
ALL ACCESS PASS
$
7
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiActuate Therapeutics, Inc. Stock Forecast
-
Is Actuate Therapeutics, Inc. Stock Undervalued?The current Actuate Therapeutics, Inc. [ACTU] share price is $7.35. The Score for ACTU is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
ACTU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Actuate Therapeutics, Inc. Stock Go Up Next Year?
Data Unavailable
Actuate Therapeutics, Inc. Stock Rating
Data Unavailable
Actuate Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
actuatetherapeutics.com
52-Week Data
52-Week High:
11.99
52-Week Low:
5.47
Prediction Charts
Market Cap:
170.8M
Price in USD:
7.35
Volume:
57.1K
Beta:
-0.36
Technical Analysis
SMA50:
6.87
SMA100:
7.18
SMA200:
7.62
52-Wk Change:
-16.1%
Stock Predictions
-
Is Actuate Therapeutics, Inc. stock public?Yes, Actuate Therapeutics, Inc. is a publicly traded company.
-
What is the Actuate Therapeutics, Inc. stock quote today?The Actuate Therapeutics, Inc. stock price is 7.35 USD today.
-
How to buy Actuate Therapeutics, Inc. stock online?You can buy Actuate Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-17 | 5.83 | 5.92 | 6.16 | 5.75 |
| Nov-18 | 5.83 | 6.10 | 6.15 | 5.80 |
| Nov-19 | 5.95 | 5.85 | 6.26 | 5.78 |
| Nov-20 | 5.88 | 6.09 | 6.25 | 5.61 |
| Nov-21 | 6.08 | 6.31 | 6.33 | 5.99 |
| Nov-24 | 6.38 | 6.26 | 6.49 | 6.10 |
| Nov-25 | 6.22 | 6.25 | 6.48 | 6.17 |
| Nov-26 | 6.09 | 6.90 | 7.01 | 5.80 |
| Nov-28 | 6.77 | 7.63 | 7.79 | 6.68 |
| Dec-1 | 7.50 | 7.17 | 7.50 | 7.05 |
| Dec-2 | 7.28 | 7.33 | 7.34 | 7.12 |
| Dec-3 | 7.36 | 7.43 | 7.49 | 7.20 |
| Dec-4 | 7.43 | 7.35 | 7.50 | 7.23 |
| Dec-5 | 7.48 | 7.35 | 7.64 | 7.30 |
Actuate Therapeutics, Inc. Earnings
Data Unavailable
Actuate Therapeutics, Inc. Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.08 per share, and a decrease next year of $0.00 per share.
* Actuate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.